Jamaica vs North Macedonia: Average non-HDL cholesterol levels
Jamaica
3.6
in 2018
North Macedonia
3.6
in 2018
Jamaica rank
30th
North Macedonia rank
30th
Average non-HDL cholesterol levels over time
- Jamaica
- North Macedonia
How they compare
Jamaica currently reports 3.6 against 3.6 in North Macedonia, a difference of 0.
Across all 39 years both countries report, North Macedonia has been ahead every year.
Jamaica ranks 30th and North Macedonia ranks 30th of 191 countries.
North Macedonia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Jamaica | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 3.4 | 4.2 | 0.8 | North Macedonia |
| 1990s | 3.31 | 4.1 | 0.79 | North Macedonia |
| 2000s | 3.32 | 3.9 | 0.58 | North Macedonia |
| 2010s | 3.48 | 3.71 | 0.2333 | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average non-hdl cholesterol levels, Jamaica or North Macedonia?
- Jamaica, at 3.6 against 3.6 in North Macedonia as of 2018.
- What is the difference in average non-hdl cholesterol levels between Jamaica and North Macedonia?
- 0, with Jamaica ahead.
- How many years of comparable data are there for Jamaica and North Macedonia?
- 39 years are reported by both, from 1980 to 2018.
- How do Jamaica and North Macedonia rank globally for average non-hdl cholesterol levels?
- Jamaica ranks 30th and North Macedonia ranks 30th of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated average level of non-high-density lipoprotein (non-HDL) cholesterol, commonly known as "bad cholesterol". Healthy levels are considered to be under 4mmol/L. Elevated levels of non-HDL cholesterol are a risk factor for chronic complications, including cardiovascular disease, and premature death.